<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"central lymph node dissection":1,
"central lymph nodes":1,
"differentiated thyroid cancer":3,
"radioactive iodine ablation":2,
"thyroid cancer":9,
"thyroid carcinoma":8,
"thyroidectomy":5,
"whole body scan":1,
"Ephb4":1,
"Ephrinb2":1,
"epidermal growth factor receptor (EGFR)":1,
"gene":1,
"papillary":3,
"thyroid":8,
"aspiration":1,
"biopsy":1,
"nodule":2,
"thyroid gland":3,
"ultrasound":2,
"core needle biopsy":1,
"fine needle aspiration":2,
"thyroid nodule":2,
"FNAB":2,
"Ultrasound elastography":1,
"lung cancer":2,
"pleural":1,
"Abdominal obesity":1,
"Cancer":2,
"Cáncer":1,
"Obesidad":1,
"Obesidad abdominal":1,
"Obesity":1,
"Obesity prevalence":1,
"Overweight":1,
"Prevalencia obesidad":1,
"Sobrepeso":1,
"elastography":1,
"thyroid nodules":2,
"Curcumin":1,
"K1 papillary thyroid cancer cell":1,
"hypoxia-inducible factor-1α":1,
"metastasis":5,
"UHRF1":1,
"hepatocellular carcinoma":1,
"negatively regulation":1,
"thyroid hormone receptor":1,
"tumor suppressor":1,
"Anaplastic thyroid carcinoma":1,
"Lymphoma":2,
"Melanoma":2,
"Sarcoma":1,
"Carcinoma":1,
"Neck":2,
"Radiotherapy":3,
"Thymus-like differentiation":1,
"Thyroid neoplasms":3,
"Incidence":3,
"Korea":1,
"Neoplasms":3,
"Time trends":1,
"Cytopathology":2,
"FNA":3,
"Nomenclature":1,
"Reporting":1,
"Terminology":1,
"fine-needle aspiration cytology":1,
"gene expression testing":1,
"molecular alteration testing":1,
"oncogene":1,
"papillary thyroid cancer":2,
"pediatric thyroid cancer":1,
"radiation":1,
"rearranged during transfection":1,
"Histopathological feature":1,
"Primary thyroid lymphoma":1,
"Sonographic profile":1,
"5-Methylcytidine":1,
"Follicular adenoma":1,
"Follicular carcinoma":2,
"LINE-1":1,
"Methylation":2,
"Papillary carcinoma":3,
"STK11":1,
"neuroblastoma":1,
"next generation sequencing":1,
"pediatric":2,
"Basaloid squamous carcinoma":1,
"Medullary thyroid carcinoma":2,
"Merkel cell carcinoma":1,
"Olfactory neuroblastoma":1,
"Rhabdomyosarcoma":1,
"SNUC":1,
"dynamic risk-stratification":1,
"low-risk":1,
"radioiodine therapy":1,
"remnant ablation":1,
"Waldenström macroglobulinemia":1,
"epidemiology":1,
"lymphoplasmacytic lymphoma":1,
"secondary malignancies":1,
"Bethesda":1,
"Fine needle biopsy":1,
"Colorectal cancer":1,
"PKM":1,
"PTB1":1,
"Warburg effect":1,
"miR-124":1,
"ACTH = adrenocorticotropic hormone":1,
"ASA = American Society of Anesthesiologists":1,
"GH = growth hormone":1,
"PA = pituitary adenoma":1,
"PRL = prolactin":1,
"SIADH = syndrome of inappropriate antidiuretic hormone":1,
"TSH = thyroid-stimulating hormone":1,
"elderly":1,
"endoscopy":1,
"pituitary adenomas":1,
"pituitary surgery":1,
"transsphenoidal":1,
"Involved node":1,
"involved site":1,
"second malignancy":1,
"AgNOR":1,
"paraffin embedded tissue sections":1,
"CT":1,
"MRI":1,
"carotid body tumor":1,
"chemodectoma":1,
"dog":1,
"paraganglioma":2,
"Cervical lymphatic malformation":1,
"Cervical teratoma":1,
"Cervical thyroid cyst":1,
"Cervical vascular malformation":1,
"Fetal neck mass":1,
"TTF-1":1,
"napsin A":2,
"pleural effusion":1,
"thyroglobulin":5,
"thyroid function test":1,
"thyroid nodule evaluation":1,
"thyrotropin":1,
"BRAF V600E":1,
"Russian Federation":1,
"FDG":1,
"PET":2,
"PET/CT":2,
"Parotid incidentaloma":1,
"Parotid mass":1,
"Thyroid remnant":1,
"NGS":1,
"NSCLC":1,
"PAX8":2,
"thyroid metastasis":1,
"Breast":1,
"Cancer pédiatrique":1,
"Cancers secondaires":1,
"Pediatric cancer":1,
"Recommandation":1,
"Recommendation":1,
"Secondary cancers":1,
"Sein":1,
"Survivant":1,
"Survivor":1,
"Thyroïde":1,
"Anaplastic thyroid cancer":2,
"Copper-64":1,
"Dosimetry":2,
"Photothermal ablation therapy":1,
"Positron emission tomography":1,
"Hashimoto’s thyroiditis":1,
"multifocal nodules":1,
"papillary thyroid carcinoma":7,
"thyroid peroxidase antibodies":1,
"Autonomously functioning thyroid nodule":1,
"meta-analysis":2,
"nodular goitre":1,
"scintigraphy":1,
"thyroid-stimulating hormone":1,
"Torin2":1,
"mTOR":1,
"mTORC1 inhibitor":1,
"quantitative high-troughput screening":1,
"Follicular thyroid neoplasia":1,
"differential diagnostics":1,
"goitre":1,
"immunohistochemistry":2,
"stem cell marker":1,
"Nonrecurrent inferior laryngeal nerve":1,
"laryngeal morbidity":1,
"ultrasonography":3,
"Dedifferentiated thyroid carcinoma":1,
"Histone deacetylase":1,
"Na(+)/I(−) symporter":1,
"Radioiodine-sensitivity":1,
"miR-146b":1,
"Clear cell carcinoma":1,
"Endometrial carcinoma":1,
"Ovarian carcinoma":1,
"Larynx":1,
"Malignancies":1,
"Nasopharynx":1,
"Oral cavity":1,
"Oropharynx":1,
"Salivary":1,
"Nasal carcinoma":1,
"Sinonasal carcinoma":1,
"Sinonasal malignancies":1,
"Skull base cancers":1,
"Heterophilic antibodies":1,
"Interference":1,
"Rheumatoid factor":1,
"Fab":1,
"HER2":1,
"PASylation":1,
"plasma half-life":1,
"Airway reconstruction":1,
"Propanolol":1,
"Subglottic hemangioma":1,
"General practitioner":1,
"Internal medicine":1,
"Long-term follow-up":1,
"Médecin généraliste":1,
"Médecine interne":1,
"Oncologie pédiatrique":1,
"Paediatric oncology":1,
"Quality of life":1,
"Qualité de vie":1,
"Suivi à long terme":1,
"Therapeutic education":1,
"Éducation thérapeutique":1,
"iodine diet":1,
"radioiodine ablation therapy":1,
"N1a":1,
"N1b":1,
"event free survival":1,
"overall survival":1,
"Prognosis":1,
"Tumor-associated macrophage":1,
"anthracycline":1,
"carboplatin":1,
"clinical trial":1,
"neoadjuvant chemotherapy":1,
"pathological complete response":1,
"trastuzumab":1,
"Adenocarcinoma":2,
"Anaplastic large cell lymphoma kinase":1,
"Anaplastic lymphoma kinase":1,
"Lung":1,
"in situ hybridization, fluorescence":1,
"(18)F-DOPA":1,
"(18)F-FDG":1,
"(68)Ga-DOTANOC":1,
"Medullary thyroid cancer":3,
"Neuroendocrine tumors":1,
"Pheochromocytoma":1,
"Children":1,
"Hemangioma":1,
"Organ doses":1,
"Radium treatment":1,
"fine-needle aspiration":1,
"head and neck ultrasound":1,
"sonography":1,
"Carcinoma papilar":1,
"Glândula tireoide":1,
"Neoplasias da glândula tireoide":1,
"Tireoidectomia":1,
"Cancer epidemiology":1,
"Cancer incidence":1,
"Mt Etna pollution":1,
"Volcanic Carcinogens":1,
"Volcanic environment":1,
"C-cell hyperplasia":1,
"Calcitonin":1,
"RET":2,
"calcium stimulation test":1,
"Tumor M2-pyruvate kinase":1,
"cancer type":1,
"distant metastases":1,
"nodal metastases":1,
"tumor size":2,
"tumor stage":1,
"Differentiated Thyroid Carcinoma":1,
"Radioiodine":1,
"Remnant Thyroid Ablation":1,
"AHI":1,
"AHI (arginine hydrochloride injection)":1,
"Kystes thyroïdiens":1,
"Recurrence":1,
"Récidive":1,
"Thyroid cysts":1,
"Traitement":1,
"Treatment":1,
"Cytology":2,
"Head and Neck Neoplasms":1,
"Lymph Nodes":1,
"Sensitivity and Specificity: Salivary Glands":1,
"Platelet activation":1,
"mean platelet volume":1,
"platelet count":1,
"Bone metastasis":1,
"whole body iodine scans":1,
"adverse events":1,
"tyrosine kinase inhibitors":1,
"vandetanib":1,
"Lambert-Eaton myasthenic syndrome":1,
"mediastinal":1,
"small cell lung cancer":1,
"epidermal growth factor receptor":1,
"estrogen receptor α":1,
"progesterone receptor":1,
"crisis":1,
"poorly-differentiated":1,
"sunitinib":1,
"microbubbles":1,
"classical":1,
"follicular":1,
"nasal cavity":2,
"thyroid neoplasm":1,
"endoscopic endonasal":1,
"parapharyngeal space":1,
"transcervical":1,
"transmaxillary-transpterygoid":1,
"Carcinoma, Papillary":1,
"Jugular Veins":1,
"Neoplasm Invasiveness":1,
"Randomized controlled trial":1,
"vandetinib":1,
"ALK":1,
"BRAF":1,
"TERT":1,
"hobnail variant":1,
"Breast cancer":1,
"pyruvate kinase M2":1,
"vascular endothelial growth factor-C":1,
"Apoptosis":1,
"cytotoxicity":1,
"inhibited":1,
"oxidative stress":1,
"Sodium iodide symporter":1,
"aggressiveness":1,
"HLA-DQB1":1,
"HLA-DRB1":1,
"cervical cancer":1,
"cytokines":1,
"genetic polymorphism":1,
"hpv16":1,
"Follicular thyroid cancer":1,
"HIV-1":1,
"long-term nonprogressor HIV infection":1,
"familial adenomatous polyposis":1,
"HCG-beta, carcinoma":1,
"germ cell tumour":1,
"non-small cell lung":1,
"CD 34":1,
"Lateral rhinotomy":1,
"Medial maxillectomy":1,
"Solitary fibrous tumour":1,
"Vimentin":1,
"Follicular lesion":1,
"Frozen section":1,
"Benzylic rearrangement":1,
"Guanidino group":1,
"Liquid chromatography-mass spectrometry":1,
"Stable isotope":1,
"Thyroid tissue":1,
"Ureido group":1,
"Renal cell carcinoma":1,
"Agenesis":1,
"isthmus":1,
"central neck dissection":1,
"lymphatic mapping":1,
"microcarcinoma":1,
"micrometastases":1,
"sentinel lymph node biopsy":1,
"MEN2":1,
"mutation":1,
"• thyroid":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2015年7月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
